Page 1 | Search Results | Hematology, ASH Education Program

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Optimizing therapy for mantle cell lymphoma

Peter Martin

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 304–309.

https://doi.org/10.1182/asheducation-2017.1.304

Published: 2017

Journal Articles

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Simon Rule

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 419–424.

https://doi.org/10.1182/asheducation-2016.1.419

Published: 2016

Journal Articles

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment

Eva Hoster, Christiane Pott

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 437–445.

https://doi.org/10.1182/asheducation-2016.1.437

Published: 2016

Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.

https://doi.org/10.1182/asheducation-2016.1.432

Published: 2016

Journal Articles

Treatment of the elderly patient with mantle cell lymphoma

Pierre Soubeyran, Rémy Gressin

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 425–431.

https://doi.org/10.1182/asheducation-2016.1.425

Published: 2016

Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.

https://doi.org/10.1182/asheducation-2013.1.568

Published: 2013

Journal Articles

Targeting B-cell receptor signaling: changing the paradigm

Nathan Fowler, Eric Davis

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 553–560.

https://doi.org/10.1182/asheducation-2013.1.553

Published: 2013

Journal Articles

Are you sure this is Waldenström macroglobulinemia?

Irene M. Ghobrial

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 586–594.

https://doi.org/10.1182/asheducation.V2012.1.586.3798562

Published: 2012

Journal Articles

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Adam Bagg

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 330–335.

https://doi.org/10.1182/asheducation-2011.1.330

Published: 2011

Journal Articles

Dreyling M, Hiddemann W; European MCL Network. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology Am Soc Hematol Educ Program . 2009;2009: 542–551 .

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 562.

https://doi.org/10.1182/asheducation.V2011.1.562.3730330b

Published: 2011

Journal Articles

Current treatment standards and emerging strategies in mantle cell lymphoma

Martin Dreyling, Wolfgang Hiddemann, for The European MCL Network

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 542–551.

https://doi.org/10.1182/asheducation-2009.1.542

Published: 2009

Journal Articles

Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways

Owen A. O’Connor

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 270–276.

https://doi.org/10.1182/asheducation-2007.1.270

Published: 2007

Journal Articles

Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Issa F. Khouri

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 390–397.

https://doi.org/10.1182/asheducation-2006.1.390

Published: 2006

Journal Articles

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Randy D. Gascoyne

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 299–306.

https://doi.org/10.1182/asheducation-2005.1.299

Published: 2005

Journal Articles

Diffuse Aggressive Lymphoma

Richard I. Fisher, Thomas P. Miller, Owen A. O'Connor

Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 221–236.

https://doi.org/10.1182/asheducation-2004.1.221

Published: 2004

Journal Articles

Rational Approaches to Design of Therapeutics Targeting Molecular Markers

Richard J. Klasa, Alan F. List, Bruce D. Cheson

Hematology Am Soc Hematol Educ Program (2001) 2001 (1): 443–462.

https://doi.org/10.1182/asheducation-2001.1.443

Published: 2001

NARROW

Molecular profiling and management of mantle cell lymphoma

Optimizing therapy for mantle cell lymphoma

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Treatment of the elderly patient with mantle cell lymphoma

Transplantation for mantle cell lymphoma: is it the right thing to do?

Targeting B-cell receptor signaling: changing the paradigm

Are you sure this is Waldenström macroglobulinemia?

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Dreyling M, Hiddemann W; European MCL Network. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology Am Soc Hematol Educ Program . 2009;2009: 542–551 .

Current treatment standards and emerging strategies in mantle cell lymphoma

Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways

Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Diffuse Aggressive Lymphoma

Rational Approaches to Design of Therapeutics Targeting Molecular Markers

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only